Matthew Carter Email & Phone Number

Wilmington, Vermont, United States

Spearhead the financial operations of the Club, overseeing all aspects of accounting, budgeting, and reporting to maximize business potential and growth.Develop and implement transformative finance processes and automated systems to drive efficiency and cost-effectiveness.Collaborate closely with the GM/Executive Director and Management team to evaluate operating results, providing actionable insights on costs and profit trends.Prepare detailed monthly financial statements and forecasts, with a focus on operational and capex budgets, monitoring variances and advising management on potential improvements.Successfully managed relationships with external auditors, ensuring compliance and alignment with Club policies.Led the recruitment and professional development of the finance team, fostering a high-performance culture and ensuring top-tier talent is in place.

Salem, Massachusetts, United States

Played a pivotal leadership role in launching this privately held analytical laboratory startup. The company was in the process of being sold to a PE-backed national laboratory. Led integration activities, assimilating cultures and reporting processes. Overseeing all finance and accounting functions, I optimize projections, accounts payable (AP), accounts receivable (AR), payroll, insurance, auditing, treasury, and financial planning and analysis (FP&A). I perform thorough due diligence for corporate acquisition, supervise the work of outside legal, tax, and accounting firms, and coordinate benefit programs. While maximizing cash flow, I prioritize growth and operational excellence.DELIVERED RESULTS:► Positioning CDX Analytics for sale to a private equity firm. ► Growing the company from $0 to $7M, and to 54 employees. ► Empowering the company to uphold its #1 market position as the statewide competition grew from 2 labs to 8+.► Forming advantageous partnerships with reputable banks and payroll companies in a highly regulated environment. ► Successfully guiding the company through multiple provider transitions due to shifting industry dynamics.► Significantly improving reporting systems and financial decision-making by introducing metrics, dashboards, and accounting controls. ► Quickly achieving profitability and doubling lab capacity twice. Developing contractor budgets and collecting quotes. Determining personnel and equipment capacity. Sourcing the initial equipment provider, Thermo Fisher Scientific. ► Optimizing the deal flow by compiling a list of 400+ potential acquisition targets, building a database and performing market research.► Partnering with the COO to effectively manage the entire staff and foster productive culture, running the Sales, Marketing, and Human Resources (HR) departments in the CEO’s absence.

Salem, Ma

I continually improved accounting, treasury, finance, HR, FP&A, AR, and AP functions for this clinical diagnostics laboratory, and assumed additional executive leadership responsibilities upon the departure of the CEO and COO in 2015. While managing the business, I maximized reimbursement and compliance. I led and motivated 3 direct reports and 15 indirect reports to peak performance levels. DELIVERED RESULTS:► Producing a high-impact sales force expansion plan and accurate 3-year financial projections in partnership with McKinsey & Company, a global management consulting firm. Analyzing the product sales/profit potential by state.► Improving financial reporting and key performance indicators (KPIs) while working with a joint venture (JV) partner in the United Kingdom.►►► Leading the successful $50M sale of the company in just 3 months after starting with Commonwealth Laboratories owners’ $200K initial equity investment. Selling the US and Canada rights to Valeant Pharmaceuticals, a Fortune 500 company, in August 2015: – Integrating processes and migrating financial systems from QuickBooks to Peoplesoft and Hyperion Financials.– Creating/presenting departmental budgets and quarterly business reviews to Valeant executive management.– Completing financial due diligence, ensuring quick turnaround from the Letter of Intent (LOI) to closing, and directing corporate wind-down activities after integration.

Lynn, Massachusetts, United States

Playing a critical role in growing this small regional lab into a $17M national toxicology laboratory with 150 employees, I provided expert accounting, finance, and P&L management while overseeing AR, AP, billing, and general ledger (GL) accounting. I created departmental budgets and cash flow forecasts while leading accounting audits and financial/non-financial due diligence. In addition, I defined and met KPIs for the business and the PE firm, all while steering 4 direct reports and 30 cross-functional indirect reports.DELIVERED RESULTS:► Eliminating 32 hours/week in manual labor by automating RCM processes.► Fostering transparency while sharing key business metrics. Designing dashboards and delivering informative presentations to the Board of Directors (BOD) and leaders across business units.► Maximizing profits and operating capital during changing reimbursement cycles by strategizing/executing multiple lean restructuring plans and implementing 13-week cash flows.►►► Successfully selling the company to Ampersand Partners for $12.5M in September 2012 and integrating it with Calloway Labs. Working closely with an investment bank to prepare financial statements and complete multiple rounds of due diligence for potential acquirers.– Taking over the responsibilities of the outgoing CEO, COO, and Head of Sales, overseeing RCM, Customer Service, Accounting, and Sales.– Integrating policies, processes, and best practices across organizations while winding down the acquired company.– Being appointed to the Account Opening Committee to deliver account profitability analyses/projections, review insurance coverage, and bring accounts into compliance.

I strategized sales and marketing plans based on customer feedback and market assessment. To increase lab capabilities and Medicaid licensing/credentialing, I collaborated across departments. I planned and attended conferences.DELIVERED RESULTS:► Driving annual revenue growth from $10M to $17M and expanding the sales team from 4 employees to 10 while turning this regional brand into a national company operating across 26 states.► Implementing ACT! CRM, developing the new website, and producing marketing/training materials.

Danvers, Massachusetts, United States

VasoActive Pharmaceuticals focused on the commercialization of over-the-counter pharmaceuticals, leveraging the proprietary VALE (Vaso Active Lipid Encapsulated) technology. The company successfully introduced three products specializing on topical pain relief and athlete’s foot treatment.• Collaborated with the CEO, underwriter, and legal team to navigate the IPO process, resulting in the successful raising of $7.5 million in funds.• Developed and coordinated a comprehensive road show, annual meeting, and investor meetings, ensuring effective communication and engagement with potential stakeholders.• Assumed responsibility for investor inquiries and correspondence following the public offering, addressing queries and providing timely and accurate information.• Delivered persuasive product presentations to major national supermarket chains, leading to an impressive expansion of distribution points from 0 to over 1,000 locations.• Worked closely with the CEO and hedge funds to facilitate a $7.5 million PIPE financing, contributing to the company's financial stability and growth.

Aquamer was a publicly traded company specializing in the commercialization of an injectable polymer for treating urological, gastroenterological, and dermal disorders. During my tenure, I played a key role in executing a successful reverse merger, collaborating closely with company owners, outside accountants, and a market maker.• Spearheaded the execution of a reverse merger, facilitating the transition from a privately held entity to a publicly traded company.• Worked closely with company owners to develop and implement strategic initiatives for the commercialization of the injectable polymer.• Collaborated with outside accountants to ensure accurate financial reporting and compliance with regulatory requirements.• Engaged with a market maker to optimize the company's positioning in the financial market.• Contributed to capital-raising efforts, exploring opportunities for venture capital investment and securing funding for business expansion.

Boston, Massachusetts, United States

Mba

Bachelor Of Arts - Ba, Biology

Activities and Societies: Football